Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive Patients
Completed · Phase 2
Conditions studied: Hypertension
In brief
The purpose of this study is to determine whether the relaxation response is more effective than attention control in reducing blood pressure and medication dosage in elderly adults with isolated systolic hypertension.
Key facts
- Study ID
- NCT00179543
- Run by
- Beth Israel Deaconess Medical Center
- People needed
- 122
- Starts
- 2001-08-01
- Last updated by the study team
- 2006-09-19
Who can join
Age: 55 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 55 years or older
- currently taking at least 2 anti-hypertensive medications
- systolic blood pressure between 140-159 mmHg
- diastolic blood pressure less than 90 mmHg
- read and understand English
- access to a telephone
- ability to attend all study visits
You may not qualify if…
- other cardiovascular disease
- major medical illness
- previous experience with any RR eliciting technique
- current use of:beta-agonist bronchodilators, systemic corticosteroids, anti-convulsants/psychotics, immunosuppressants, cytotoxic therapy, anabolic steroids, antidepressants (other than SSRIs), dicyclomine, bile acid binding resins, or sympathomimetic medication
Where it is running
- BIDMC — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.